skip to main content
Idioma:
Mostrar Somente
Refinado por: autor: Calandra, G remover Base de dados/Biblioteca: ScienceDirect (Elsevier) remover autor: Bridger, Gary remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction
Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction

Devine, Steven M. ; Vij, Ravi ; Rettig, Michael ; Todt, Laura ; McGlauchlen, Kiley ; Fisher, Nicholas ; Devine, Hollie ; Link, Daniel C. ; Calandra, Gary ; Bridger, Gary ; Westervelt, Peter ; DiPersio, John F.

Blood, 2008-08, Vol.112 (4), p.990-998 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma
Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma

DiPersio, John F. ; Stadtmauer, Edward A. ; Nademanee, Auayporn ; Micallef, Ivana N.M. ; Stiff, Patrick J. ; Kaufman, Jonathan L. ; Maziarz, Richard T. ; Hosing, Chitra ; Früehauf, Stefan ; Horwitz, Mitchell ; Cooper, Dennis ; Bridger, Gary ; Calandra, Gary

Blood, 2009-06, Vol.113 (23), p.5720-5726 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
3
12 Months Report from a Phase 3 Study of Plerixafor+G-CSF Vs. Placebo+G-CSF for Mobilization of Hematopoietic Stem Cell for Autologous Transplant in Patients with Multiple Myeloma
12 Months Report from a Phase 3 Study of Plerixafor+G-CSF Vs. Placebo+G-CSF for Mobilization of Hematopoietic Stem Cell for Autologous Transplant in Patients with Multiple Myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

12 Months Report from a Phase 3 Study of Plerixafor+G-CSF Vs. Placebo+G-CSF for Mobilization of Hematopoietic Stem Cell for Autologous Transplant in Patients with Multiple Myeloma

DiPersio, John F. ; Stadtmauer, Edward A. ; Nademanee, Auayporn P. ; Micallef, Ivana NM ; Stiff, Patrick J. ; Bridger, Gary ; Calandra, Gary

Blood, 2008-11, Vol.112 (11), p.3312-3312 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
4
Months Report from the Phase 3 Study of Plerixafor+G-CSF VS. Placebo+G-CSF for Mobilization of Hematopoietic Stem Cell for Autologous Transplant in Patients with NHL
Months Report from the Phase 3 Study of Plerixafor+G-CSF VS. Placebo+G-CSF for Mobilization of Hematopoietic Stem Cell for Autologous Transplant in Patients with NHL
Material Type:
Artigo 		Adicionar ao Meu Espaço

Months Report from the Phase 3 Study of Plerixafor+G-CSF VS. Placebo+G-CSF for Mobilization of Hematopoietic Stem Cell for Autologous Transplant in Patients with NHL

DiPersio, John F. ; Micallef, Ivana NM ; Stiff, Patrick J. ; Bolwell, Brian J. ; Maziarz, Richard Thomas ; Bridger, Gary ; Calandra, Gary

Blood, 2008-11, Vol.112 (11), p.1136-1136 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
5
Transplanted CD34+ Cell Dose Is Associated with Long-Term Platelet Count Following Autologous Hematopoietic Stem Cell Transplant in Patients with Non-Hodgkin's Lymphoma and Multiple Myeloma
Transplanted CD34+ Cell Dose Is Associated with Long-Term Platelet Count Following Autologous Hematopoietic Stem Cell Transplant in Patients with Non-Hodgkin's Lymphoma and Multiple Myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Transplanted CD34+ Cell Dose Is Associated with Long-Term Platelet Count Following Autologous Hematopoietic Stem Cell Transplant in Patients with Non-Hodgkin's Lymphoma and Multiple Myeloma

Stiff, Patrick J. ; Micallef, Ivana NM ; Nademanee, Auayporn P. ; Stadtmauer, Edward A. ; Maziarz, Richard Thomas ; Bolwell, Brian J. ; Bridger, Gary ; Calandra, Gary ; Angell, Jennifer ; DiPersio, John F.

Blood, 2008-11, Vol.112 (11), p.2175-2175 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
6
Successful Stem Cell Mobilization Rescue by AMD3100 (Plerixafor)+G-CSF for Patients Who Failed Primary Mobilization: Results from the Phase III (3101-NHL) Study
Successful Stem Cell Mobilization Rescue by AMD3100 (Plerixafor)+G-CSF for Patients Who Failed Primary Mobilization: Results from the Phase III (3101-NHL) Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Successful Stem Cell Mobilization Rescue by AMD3100 (Plerixafor)+G-CSF for Patients Who Failed Primary Mobilization: Results from the Phase III (3101-NHL) Study

Micallef, Ivana ; Stiff, Patrick J. ; DiPersio, John F. ; Maziarz, Richard Thomas ; McCarty, John M. ; Angell, Jennifer ; Bridger, Gary ; Calandra, Gary ; on behalf of the Investigators

Blood, 2007-11, Vol.110 (11), p.602-602 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
7
Successful Stem Cell Remobilization Using Plerixafor (Mozobil) Plus Granulocyte Colony-Stimulating Factor in Patients with Non-Hodgkin Lymphoma: Results from the Plerixafor NHL Phase 3 Study Rescue Protocol
Successful Stem Cell Remobilization Using Plerixafor (Mozobil) Plus Granulocyte Colony-Stimulating Factor in Patients with Non-Hodgkin Lymphoma: Results from the Plerixafor NHL Phase 3 Study Rescue Protocol
Material Type:
Artigo 		Adicionar ao Meu Espaço

Successful Stem Cell Remobilization Using Plerixafor (Mozobil) Plus Granulocyte Colony-Stimulating Factor in Patients with Non-Hodgkin Lymphoma: Results from the Plerixafor NHL Phase 3 Study Rescue Protocol

Micallef, Ivana N ; Stiff, Patrick J ; DiPersio, John F ; Maziarz, Richard T ; McCarty, John M ; Bridger, Gary ; Calandra, Gary

Biology of blood and marrow transplantation, 2009-12, Vol.15 (12), p.1578-1586

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
8
Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction. Commentary
Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction. Commentary
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction. Commentary

GRATWOHL, Alois ; WODNAR-FILIPOWICZ, Aleksandra ; CALANDRA, Gary ; BRIDGER, Gary ; WESTERVELT, Peter ; DIPERSIO, John F ; DEVINE, Steven M ; VIJ, Ravi ; RETTIG, Michael ; TODT, Laura ; MCGLAUCHLEN, Kiley ; FISHER, Nicholas ; DEVINE, Hollie ; LINK, Daniel C

Blood, 2008, Vol.112 (4) [Periódico revisado por pares]

Washington, DC: The Americain Society of Hematology

Texto completo disponível

Citações Citado por
9
HLA-Matched Sibling Donor Stem Cell Mobilization Can Be Safely and Effectively Reduced from a Five Day to a One Day Process by a Direct Antagonist of the CXCR4/SDF-1 Interaction
HLA-Matched Sibling Donor Stem Cell Mobilization Can Be Safely and Effectively Reduced from a Five Day to a One Day Process by a Direct Antagonist of the CXCR4/SDF-1 Interaction
Material Type:
Artigo 		Adicionar ao Meu Espaço

HLA-Matched Sibling Donor Stem Cell Mobilization Can Be Safely and Effectively Reduced from a Five Day to a One Day Process by a Direct Antagonist of the CXCR4/SDF-1 Interaction

Devine, Steven M. ; Vij, Ravi ; Todt, Laura ; McLaughlin, Kiley ; Fisher, Nicholas ; Morris, Natalie ; Link, Daniel C. ; Calandra, Gary ; Bridger, Gary ; DiPersio, John F.

Blood, 2006-11, Vol.108 (11), p.53-53 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
10
Massive Mobilization of AML Cells into Circulation by Disruption of Leukemia/Stroma Cell Interactions Using CXCR4 Antagonist AMD3100: First Evidence in Patients and Potential for Abolishing Bone Marrow Microenvironment-Mediated Resistance
Massive Mobilization of AML Cells into Circulation by Disruption of Leukemia/Stroma Cell Interactions Using CXCR4 Antagonist AMD3100: First Evidence in Patients and Potential for Abolishing Bone Marrow Microenvironment-Mediated Resistance
Material Type:
Artigo 		Adicionar ao Meu Espaço

Massive Mobilization of AML Cells into Circulation by Disruption of Leukemia/Stroma Cell Interactions Using CXCR4 Antagonist AMD3100: First Evidence in Patients and Potential for Abolishing Bone Marrow Microenvironment-Mediated Resistance

Andreeff, Michael ; Konoplev, Sergej ; Wang, Rui-Yu ; Zeng, Zhihong ; McQueen, Teresa ; Shi, Yue-Xi ; Medeiros, L. Jeffrey ; Estey, Elihu ; McCarty, John M. ; Elkins, Stephanie ; Champlin, Richard ; Calandra, Gary ; Bridger, Gary ; Konopleva, Marina

Blood, 2006-11, Vol.108 (11), p.568-568 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (10)

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.